Related Experiment Video
Updated: Jul 6, 2026

10:01
Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
Novel approach to structure-based pharmacophore search using computational geometry and shape matching techniques
Jerry Osagie Ebalunode1, Zheng Ouyang, Jie Liang
1Department of Pharmaceutical Sciences, BRITE Institute, North Carolina Central University, 1801 Fayetteville Street, Durham, North Carolina 27707, USA.
Journal of Chemical Information and Modeling
|April 10, 2008
Summary
A new structure-based pharmacophore search method, Shape4, enables efficient virtual screening using empty crystal structures. This method improves hit identification and diversity in drug discovery research.
Area of Science:
- Computational chemistry
- Drug discovery
- Structural biology
Background:
- Structure-based virtual screening (SBVS) methods accelerate drug discovery by analyzing molecular structures.
- Existing SBVS methods often rely on detailed molecular docking, which can be computationally intensive.
- Rapid overlay of chemical structures (ROCS) is a shape-based method using ligand structures as queries.
Purpose of the Study:
- To develop and validate a novel structure-based pharmacophore search method (Shape4) for efficient virtual screening.
- To adapt shape-based screening to utilize empty crystal structures, expanding its applicability.
- To improve hit identification and diversity in drug discovery pipelines.
Main Methods:
- Shape4 employs a variant of ROCS shape technology with empty crystal structures.
- A computational geometry method and geometric casting algorithm generate a pseudoligand (negative image) of the target binding site.
- An efficient shape comparison algorithm from the OE SHAPE Toolkit matches molecules to the pseudoligand.
Main Results:
- Shape4 was computationally validated using known biologically active compounds from the WOMBAT database.
- Virtual screening experiments on five targets showed Shape4 achieved similar or better enrichment ratios compared to other methods.
- The method often produced greater diversity among top-ranking computational hits.
Conclusions:
- Shape4 offers an efficient and effective structure-based virtual screening approach.
- The method's ability to use empty crystal structures broadens its utility in drug discovery.
- Shape4 enhances hit identification and diversity, contributing to more robust lead generation.
Related Concept Videos
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

